Pulmonary hypertension in critical care

Current Opinion in Critical Care

Volumn 17, Issue 5, 2011, Pages 439-448

  Gayat, Etienne ^a,b   Mebazaa, Alexandre ^a,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

^c University of Paris   (France)

Author keywords

acute cor pulmonale; acute respiratory distress syndrome; intensive care; pulmonary hypertension

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LEVOSIMENDAN; NITROPRUSSIDE SODIUM; PROSTACYCLIN; SILDENAFIL; TADALAFIL; TROPONIN I;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; ECHOCARDIOGRAPHY; ERECTILE DYSFUNCTION; HEART CATHETERIZATION; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART STROKE VOLUME; HUMAN; IMAGE RECONSTRUCTION; INTENSIVE CARE; INTENSIVE CARE UNIT; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; MEDICAL SOCIETY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; THREE DIMENSIONAL IMAGING; TRICUSPID VALVE REGURGITATION; VASCULARIZATION;

CRITICAL CARE; HUMANS; HYPERTENSION, PULMONARY;

EID: 80052748273     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32834a7619     Document Type: Review

References (58)

1. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55-S66.
2. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34:888-894.
3. Matthay RA, Arroliga AC, Wiedemann HP, et al. Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest 1992; 101:255S-262S.
4. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure: from pathophysiology to new treatments. Intensive Care Med 2004; 30:185-196. (Pubitemid 38253407)
5. Vieillard-Baron A, Schmitt JM, Augarde R, et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med 2001; 29:1551-1555. (Pubitemid 32762335)
6. Vieillard-Baron A, Prin S, Chergui K, et al. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 2002; 166:1310-1319. (Pubitemid 35292695)
7. Jardin F. Ventricular interdependence: how does it impact on hemodynamic evaluation in clinical practice? Intensive Care Med 2003; 29:361-363. (Pubitemid 36379434)
8. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S.
9. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54:S43-54.
10. Tsapenko MV, Tsapenko AV, Comfere TB, et al. Arterial pulmonary hypertension in noncardiac intensive care unit. Vasc Health Risk Manag 2008; 4:1043-1060.
11. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27:1481-1486. (Pubitemid 32835316)
12. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30:1165-1171.
13. Jardin F, Gueret P, Dubourg O, et al. Two-dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure. Crit Care Med 1985; 13:952-956. (Pubitemid 16229651)
14. Squara P, Dhainaut JF, Artigas A, Carlet J. Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study. Intensive Care Med 1998; 24:1018-1028. (Pubitemid 28497818)
15. Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998; 158:1076-1081. (Pubitemid 28489004)
16. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
17. Osman D, Monnet X, Castelain V, et al. Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome. Intensive Care Med 2009; 35:69-76.
18. Vieillard-Baron A. Is right ventricular function the one that matters in ARDS patients? Definitely yes. Intensive Care Med 2009; 35:4-6.
19. RamakrishnaG, Sprung J, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45:1691-1699. (Pubitemid 40704508)
20. Hoeper MM, Galie N, Murali S, et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165:341-344. (Pubitemid 34118506)
21. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-2537.
22. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119:2250-2294.
23. Mayo PH, Beaulieu Y, Doelken P, et al. American College of Chest Physicians/ La Societe de Reanimation de Langue Francaise statement on competence in critical care ultrasonography. Chest 2009; 135:1050-1060.
24. Sugeng L,Mor-Avi V, Weinert L, et al. Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imag 2010; 3:10-18.
25. Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002; 20:1314-1331. (Pubitemid 35339335)
26. Payen D, Gayat E. Which general intensive care unit patients can benefit from placement of the pulmonary artery catheter? Crit Care 2006; 10 (Suppl 3):S7.
27. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT investigators. JAMA 1996; 276:889-897. (Pubitemid 26301608)
28. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294:1625-1633.
29. Richard C, Warszawski J, Anguel N, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003; 290:2713-2720. (Pubitemid 37475600)
30. Ivanov R, Allen J, Calvin JE. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med 2000; 28:615-619. (Pubitemid 30174251)
31. Sakr Y, Vincent JL, Reinhart K, et al. Use of the pulmonary artery catheter is not associated with worse outcome in the ICU. Chest 2005; 128:2722-2731. (Pubitemid 41507633)
32. Rhodes A, Cusack RJ, Newman PJ, et al. A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Med 2002; 28:256-264. (Pubitemid 34230645)
33. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366:472-477. (Pubitemid 41111695)
34. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129:1313-1321.
35. Torbicki A, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108:844-848. (Pubitemid 37022127)
36. Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with nonmassive pulmonary embolism. Intensive Care Med 2007; 33:286-292. (Pubitemid 46221234)
37. La Vecchia L, Ottani F, Favero L, et al. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart 2004; 90:633-637. (Pubitemid 38668535)
38. Mehta NJ, Jani K, Khan IA. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am Heart J 2003; 145:821-825. (Pubitemid 36570952)
39. Tung RH,Garcia C, Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647. (Pubitemid 39050512)
40. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S78-S84.
41. Zamanian RT, Haddad F, Doyle RL, Weinacker AB. Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 2007; 35:2037-2050. (Pubitemid 47326439)
42. Mebazaa A, Pitsis AA, Rudiger A, et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14:201.
43. Mebazaa A, Gheorghiade M, Pina IL, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008; 36:S129-S139.
44. Morelli A, Teboul JL, Maggiore SM, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006; 34:2287-2293. (Pubitemid 44260011)
45. Mekontso Dessap A, Charron C, Devaquet J, et al. Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome. Intensive Care Med 2009; 35:1850-1858.
46. George I, Xydas S, Topkara VK, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg 2006; 82:2161-2169.
47. Lukaszewicz AC, Mebazaa A, Callebert J, et al. Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients. Crit Care Med 2005; 33:1008-1014. (Pubitemid 40638173)
48. Christenson J, Lavoie A, O'Connor M, et al. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161:1443-1449. (Pubitemid 30329010)
49. Wang T, El Kebir D, Blaise G. Inhaled nitric oxide in 2003: a review of its mechanisms of action. Can J Anaesth 2003; 50:839-846. (Pubitemid 37455542)
50. Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci 2001; 59:5-16. (Pubitemid 32117977)
51. Lowson SM, Doctor A, Walsh BK, Doorley PA. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002; 30:2762-2764. (Pubitemid 36870581)
52. Lowson SM. Inhaled alternatives to nitric oxide. Anesthesiology 2002; 96:1504-1513. (Pubitemid 34587223)
53. Lepore JJ, Maroo A, Bigatello LM, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 2005; 127:1647-1653. (Pubitemid 46218790)
54. Barst RJ, Oudiz RJ, Beardsworth A, et al. Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension. J Heart Lung Transplant 2011; 30:632-643.
55. Falk JA, Philip KJ, Schwarz ER. The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension. Vasc Health Risk Manag 2010; 6:273-280.
56. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353:1386-1389. (Pubitemid 29192409)
57. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126:401S-428S. (Pubitemid 39297960)
58. Eid-Lidt G, Gaspar J, Sandoval J, et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism. Chest 2008; 134: 54-60. (Pubitemid 352008763)